Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. anxiety treatment
Show results for
Products
Applications

Companies

News
Articles
Videos

Refine by
Date

  • Older

Anxiety Treatment Articles & Analysis

12 news found

NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players

NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players

NHL Alumni Association (NHLAA), NEEKA Health Canada("NEEKA"),and CanaQuest Medical Corp ("CanaQuest") are pleased to announce a transformative study partnership that will investigate the efficacy of Mentanine® as a potential treatment to reduce anxiety in former NHL ...

ByCanaQuest Medical Corp.


Animal Emotional Behavior Tests for Anxiety and Depression Treatment

Animal Emotional Behavior Tests for Anxiety and Depression Treatment

Anxiety and depression affect millions of individuals worldwide, leading to a significant burden on public health and impacting overall quality of life. ...

ByProtheragen


Sage Therapeutics and Biogen Present Further Analyses from Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression at the European College of Neuropsychopharmacology (ECNP) Congress

Sage Therapeutics and Biogen Present Further Analyses from Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression at the European College of Neuropsychopharmacology (ECNP) Congress

” Additional secondary endpoints showed further evidence of the potential impact of zuranolone on the reduction of other PPD related symptoms, including anxiety in these patients. Treatment with zuranolone was shown to significantly improve symptoms of anxiety at Days 3, 8, 15, and 45 (p less than 0.05, at all time points) when compared to ...

BySage Therapeutics


Cingulate Presents Data for Its Triple-Release Buspirone Product Candidate: CTx-2103

Cingulate Presents Data for Its Triple-Release Buspirone Product Candidate: CTx-2103

However, due to its short half-life, buspirone is prescribed to be taken several times a day for management of anxiety, which can be challenging for patients and may lead to sub-optimal treatment outcomes. ...

ByCingulate


Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation

Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation

Oncomfort, the Belgian inventor of and leader in Digital Sedation - a new method for relieving patients’ pain and anxiety without medication - today announces the completion of a €10 million Series A funding round co-led by two prominent institutional investors: Debiopharm and Crédit Mutuel Innovation. ...

ByOncomfort


Cingulate Announces Completion of CTx-2103 Human Formulation Study for the Treatment of Anxiety Disorders

Cingulate Announces Completion of CTx-2103 Human Formulation Study for the Treatment of Anxiety Disorders

People may live with anxiety for years before they are diagnosed or treated.2 About CTx-2103 and the Formulation Study CTx-2103 is a novel, trimodal, extended-release tablet of buspirone incorporating Cingulate’s proprietary PTR™ drug delivery platform, and is being studied for the treatment of anxiety and/or ...

ByCingulate


Neopharmed Gentili acquires Lormetazepam product portfolio to strengthen its neurology division

Neopharmed Gentili acquires Lormetazepam product portfolio to strengthen its neurology division

The transaction allows Neopharmed Gentili to strengthen its portfolio in the neuro-psychiatric area with high value-added drugs for the treatment of insomnia. Neopharmed Gentili, an Italian pharmaceutical company controlled by Ardian in partnership with the Del Bono family, which has historic roots in its territory and is pursuing international growth, announced that it has ...

ByNeopharmed Gentili S.p.A.


New Preclinical Research Published in Nature Highlights an Active Role by Microbiome-Derived Metabolites in Brain Function and Anxiety-like Behavior

New Preclinical Research Published in Nature Highlights an Active Role by Microbiome-Derived Metabolites in Brain Function and Anxiety-like Behavior

The paper, “A gut-derived metabolite alters brain activity and anxiety behavior in mice,” offers new mechanistic insight into how the gut microbiome can influence complex behaviors via the gut-brain axis. ...

ByAxial Therapeutics Inc.


Virtual Reality is being used in exciting ways to treat anxiety and depression

Virtual Reality is being used in exciting ways to treat anxiety and depression

According to a Mashable article on a study of the efficacy of VR treatment for depression and anxiety, “This type of immersive therapy is a viable and potentially revolutionizing method to treat certain mental health conditions. A blend of VRET and well–established practices in mental health treatment can both augment and enhance ...

Byni2o, Inc.


How Often should you Take CBD?

How Often should you Take CBD?

It’s not a narcotic and it can’t totally erase the sensory feeling of pain, however existing research shows that CBD can be successful in reducing pain and inflammation in the body without the troublesome side effects of other pain relievers. Helps decrease your anxiety. A 2015 study found that “CBD has considerable potential as a treatment for ...

ByMedcbdx


Oncomfort launches SILVA, its new Digital Sedation™ module

Oncomfort launches SILVA, its new Digital Sedation™ module

Oncomfort has just launched SILVA, a new module that enriches its library of solutions for the treatment of anxiety and pain for patients undergoing a medical procedure. ...

ByOncomfort


MassChallenge announces 30 digital health companies to join its 2019 cohort

MassChallenge announces 30 digital health companies to join its 2019 cohort

GYANT is a triage chatbot that employs AI to help users figure out where they should turn for treatment. GyroGear is a startup focused on helping patients with Parkinson’s disease. ...

ByEpihunter NV

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT